Cholestatic Pruritus Treatments

Evidence based guidelines recommend step wise approach:

• Ursodeoxycholic acid
• Cholestyramine - anion exchange resin,
• Rifampicin - the PXR agonist
• Naltrexone - the opioid antagonist
  
• The naltrexone dosage used was 1–2 mg/kg orally once daily with a maximum daily dosage of 50 mg.
• Sertraline - serotonin reuptake inhibitor
  
• Antihistamine 
• Others (phenobarbital, aloe vera, alimemazine)
• Livmarli
• Surgery
• Biliary diversion or ileal bypass
• Liver transplant

Note: Pruritus may remain intractable even with combination medical treatment, and at this stage, surgery or liver transplantation is indicated

Ursodeoxycholic Acid (UDCA)

Complications:

• Generally well-tolerated.
• Diarrhea (most common)
• Nausea
• Mild elevations in liver enzymes (transient)

Reasons for Treatment Failure:

• Inadequate dosing: May require higher doses than initially prescribed to be effective.
• Advanced liver disease: Less effective in advanced cholestatic conditions.
• Failure to improve bile flow: If the underlying cholestasis is severe and UDCA doesn't significantly improve bile flow, it may not alleviate pruritus.
• Non-responsiveness: Some individuals simply do not respond to UDCA.

Barriers to Use:

• Cost: Can be expensive, especially if higher doses are needed.
• Availability: May not be readily available in all areas.
• Patient adherence: Requires consistent daily dosing.

Cholestyramine (Anion Exchange Resin)

Complications:

• Gastrointestinal: Constipation (very common), bloating, abdominal pain, nausea, vomiting. Can worsen pre-existing constipation.
• Malabsorption: Can bind to and interfere with the absorption of fat-soluble vitamins (A, D, E, K) and other medications.
• Increased triglycerides: May increase serum triglyceride levels.

Reasons for Treatment Failure:

• Non-adherence: Palatability issues and GI side effects lead to poor adherence.
• Incomplete binding of bile acids: May not bind all pruritogenic bile acids effectively.
• Drug interactions: Binds to many medications, decreasing their absorption.

Barriers to Use:

• Palatability: Gritty texture and unpleasant taste.
• Administration schedule: Must be taken separately from other medications to avoid binding interactions (typically 1-2 hours before or 4-6 hours after other drugs).
• Nutritional deficiencies: Risk of fat-soluble vitamin deficiencies with long-term use.
• Exacerbation of constipation: Significant problem, especially in children.

Rifampicin (PXR Agonist)

Complications:

• Hepatotoxicity: Risk of liver damage (elevated liver enzymes, hepatitis). Requires regular monitoring of liver function.
• Drug Interactions: Potent inducer of CYP450 enzymes, leading to decreased levels of many other medications (including immunosuppressants, oral contraceptives).
• Flu-like symptoms: Fever, chills, muscle aches.
• Gastrointestinal: Nausea, vomiting, abdominal pain.
• Orange discoloration of bodily fluids: Urine, tears, sweat can turn orange (harmless but can be alarming).

Reasons for Treatment Failure:

• Drug Interactions: Can significantly reduce the efficacy of other essential medications.
• Hepatotoxicity: Limits its use due to safety concerns.
• Development of resistance: Pruritus may return with prolonged use.

Barriers to Use:

• Drug interactions: Requires careful review of the patient's medication list and potential dose adjustments.
• Liver function monitoring: Needs regular blood tests to monitor for liver damage.
• Potential for hepatotoxicity: Limits use in patients with pre-existing liver disease.

Naltrexone (Opioid Antagonist)

Complications:

• Gastrointestinal: Nausea, vomiting, abdominal pain, diarrhea, constipation (usually mild).
• Headache
• Dizziness
• Elevated liver enzymes (rare)
• Opioid withdrawal: In patients taking opioids, naltrexone can precipitate withdrawal symptoms.

Reasons for Treatment Failure:

• Individual variability: Some individuals do not respond to naltrexone for pruritus.
• Inadequate dosing: May require dose adjustments to achieve optimal effect.
• Tolerance: Pruritus may return with prolonged use.

Barriers to Use:

• Availability: May not be readily available or covered by insurance in all areas.
• Adherence: Requires consistent daily dosing.
• Caregiver/patient acceptance: Concern about potential side effects.

Sertraline (Serotonin Reuptake Inhibitor)

Complications:

• Gastrointestinal: Nausea, vomiting, diarrhea, constipation, abdominal pain.
• Neurological: Headache, dizziness, insomnia, anxiety.
• Serotonin Syndrome: Rare, but potentially life-threatening, especially when combined with other serotonergic agents.
• QT prolongation: Can prolong the QT interval on an ECG, increasing the risk of arrhythmias (rare).

Reasons for Treatment Failure:

• Individual variability: Some individuals do not respond to sertraline for pruritus.
• Delayed onset of action: Can take several weeks to achieve full effect.
• Side effects: GI and neurological side effects can limit tolerability.

Barriers to Use:

• Drug interactions: Can interact with other medications.
• QT prolongation: Requires caution in patients with pre-existing cardiac conditions or those taking other QT-prolonging drugs.
• Black Box Warning: SSRIs have a black box warning regarding increased risk of suicidal ideation and behavior in children and adolescents.

Hydroxyzine (Antihistamine)

Complications:

• Sedation: Drowsiness, fatigue (very common).
• Dry mouth
• Constipation
• Urinary retention
• Blurred vision

Reasons for Treatment Failure:

• Tolerance: Effectiveness may decrease with prolonged use.
• Sedation: Can be too sedating for some individuals, limiting its use during the day.
• Limited efficacy: Primarily effective for histamine-mediated pruritus, which may not be the primary mechanism in cholestatic pruritus.

Barriers to Use:

• Sedation: Can interfere with daily activities and school performance.
• Anticholinergic effects: Dry mouth, constipation, urinary retention can be bothersome.

Others (Phenobarbital, Aloe Vera, Alimemazine)

Phenobarbital:

Complications:

• Sedation, cognitive impairment, respiratory depression, drug interactions, potential for dependence.

Barriers:

• Significant side effect profile limits its use as a first-line agent.

Aloe Vera:

Complications:

• Generally well-tolerated when used topically. Oral aloe vera can cause diarrhea and abdominal cramping.

Barriers:

• Limited evidence of efficacy for cholestatic pruritus.

Alimemazine (Trimeprazine):

Complications:

• Similar to other antihistamines (sedation, dry mouth, constipation). Can also cause extrapyramidal side effects (rare).

Barriers:

• Sedation and anticholinergic effects limit tolerability.

Livmarli (Maralixibat)

Complications:

• Diarrhea, abdominal pain
• Bile acid malabsorption
• Fat soluble vitamin deficiency
• Rare: Liver test abnormalities

Reasons for Treatment Failure:

• Significant liver damage
• Inability to regulate bile acid production
• GI upset limiting tolerability

Barriers to Use:

• Cost: Newer medications such as this are often very expensive and insurance coverage may be difficult.
• Drug-drug interactions are possible
• Not effective in all patients with cholestatic pruritus

Surgery (Biliary Diversion or Ileal Bypass)

Complications:

• Infection
• Bleeding
• Electrolyte imbalances
• Malabsorption: Can worsen malabsorption of fat-soluble vitamins and other nutrients.
• Liver failure: Can worsen underlying liver disease.
• Short bowel syndrome: In ileal bypass, shortening of the intestine can lead to significant malabsorption and diarrhea.

Reasons for Treatment Failure:

• Progressive liver disease: Surgery may not be effective if the underlying liver disease continues to progress.
• Surgical complications: Infections, bleeding, or anastomotic leaks can lead to failure.
• Malabsorption: Can lead to significant nutritional deficiencies.

Barriers to Use:

• Invasiveness: Major surgical procedure with significant risks.
• Limited availability: Only performed at specialized centers.
• Patient suitability: Not all patients are suitable candidates for surgery.

Liver Transplant

Complications:

• Infection
• Rejection: Acute or chronic rejection of the transplanted liver.
• Biliary complications: Bile leaks, strictures.
• Vascular complications: Hepatic artery thrombosis, portal vein thrombosis.
• Immunosuppression-related complications: Increased risk of infections, malignancies, and metabolic disorders.

Reasons for Treatment Failure:

• Rejection: Liver graft failure due to rejection.
• Infection: Sepsis or opportunistic infections can lead to mortality.
• Recurrence of underlying liver disease: The original liver disease can recur in the transplanted liver.

Barriers to Use:

• Organ availability: Limited supply of donor livers.
• Patient eligibility: Must meet strict criteria to be listed for transplant.
• Surgical risks: Major surgical procedure with significant risks.
• Lifelong immunosuppression: Requires lifelong immunosuppressive medications with associated side effects.